Terazosin Capsule
Product Images NDC 50090-0657

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Terazosin (NDC 50090-0657). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500900657)

Terazosin 1 mg capsules packaging label from A-S Medication Solutions, NDC 50090-0657-0, containing 30 capsules. The label provides storage instructions to keep the capsules at 68 to 77 degrees Fahrenheit, protected from light and moisture, and indicates each capsule contains terazosin hydrochloride equivalent to 1 mg of terazosin.*

FDA Label Image

Terazosin Hydrochloride Chemical Structure (Terazosin Hydrochloride Capsules 1)

Chemical structure diagram of Terazosin Hydrochloride showing the molecular arrangement of atoms and bonds in the compound.*

FDA Label Image

Figure 1 (Terazosin Hydrochloride Capsules 2)

This image presents two line graphs comparing placebo and terazosin treatment over three months. The left graph shows mean change in total symptom score from baseline, with terazosin demonstrating a larger decrease than placebo. The right graph illustrates mean increase in peak flow rate (mL/sec) from baseline, where terazosin shows a greater increase compared to placebo. Sample sizes (N) for each group are noted as 54-55 for symptom scores and 52-54 for peak flow rates.*

FDA Label Image

Figure 2 (Terazosin Hydrochloride Capsules 3)

A line graph illustrating mean change from baseline over time in months. The vertical axis represents mean change values from 0 to -7, and the horizontal axis shows months ranging from 0 to 30. Data points are marked with circles, with some values marked by asterisks to indicate significance or emphasis.*

FDA Label Image

Figure 3 (Terazosin Hydrochloride Capsules 4)

A line graph showing the mean change from baseline in mL/sec over a 30-month period. Data points are plotted monthly from 0 to 30 months, with some points marked by asterisks indicating statistical significance. The graph includes error bars for each data point.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.